Bristol-Myers Squibb
Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
BMY Key Statistics
Stock Snapshot
The current Bristol-Myers Squibb(BMY) stock price is $51.14, with a market capitalization of 104.11B. The stock trades at a price-to-earnings (P/E) ratio of 16.29 and offers a dividend yield of 5.1%.
During the trading session on 2025-12-03, Bristol-Myers Squibb(BMY) shares reached a daily high of $51.34 and a low of $48.44. At a current price of $51.14, the stock is +5.6% higher than the low and still -0.4% under the high.
Trading activity shows a volume of 20.25M, compared to an average daily volume of 14.19M.
Over the past 52 weeks, Bristol-Myers Squibb(BMY) stock has traded between a high of $63.33 and a low of $42.52.
Over the past 52 weeks, Bristol-Myers Squibb(BMY) stock has traded between a high of $63.33 and a low of $42.52.
BMY News
Bristol Myers Squibb & Co. (NYSE:BMY) on Wednesday said it would enroll additional patients in the ADEPT-2 Phase 3 study. BMY shares are climbing with convicti...
In its recent Q3 2025 update, BioNTech reported a net loss largely tied to a contractual dispute settlement but raised full-year revenue guidance, supported by...
Bristol-Myers Squibb (BMY) has been drifting lately, with the share price down over the past year but ticking higher in the past month, and that contrast is cat...
Analyst ratings
70%
of 30 ratingsMore BMY News
Below is Validea's guru fundamental report for BRISTOL-MYERS SQUIBB CO (BMY). Of the 22 guru strategies we follow, BMY rates highest using our Low PE Investor m...
Image source: The Motley Fool. Oct. 30, 2025 at 4:06 p.m. ET Call participants Board Chair and Chief Executive Officer — Christopher Boerner Chief Financial Of...
